News
STLNW
0.0202
-40.41%
-0.0137
Weekly Report: what happened at STLN last week (0907-0911)?
Weekly Report · 6d ago
Weekly Report: what happened at STLN last week (0831-0904)?
Weekly Report · 09/07 10:11
Starling Oncology Announces Governance Transition as Director Steps Down
TipRanks · 09/02 10:31
Weekly Report: what happened at STLN last week (0824-0828)?
Weekly Report · 08/31 10:18
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 08/28 21:06
Weekly Report: what happened at STLN last week (0817-0821)?
Weekly Report · 08/24 10:18
Starling Oncology Institute Secures New $25 Million Credit Facility
TipRanks · 08/21 21:58
Oncology Institute Earnings Call Highlights Growth And Risks
TipRanks · 08/20 00:12
Major Investor Quietly Ramps Up Stake in Starling Oncology Institute
TipRanks · 08/18 02:08
Weekly Report: what happened at STLN last week (0810-0814)?
Weekly Report · 08/17 10:19
Weekly Report: what happened at STLN last week (0803-0807)?
Weekly Report · 08/10 10:14
Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Benzinga · 08/07 17:48
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/07 17:05
Starling Oncology Institute: Robust Q2, Raised FY26 Outlook and Expanded Delegated Contracts Support Buy Rating and Unchanged $7 Price Target
TipRanks · 08/07 15:26
Starling Oncology price target raised to $11 from $8 at B. Riley
TipRanks · 08/07 12:47
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 08/07 12:05
Starling Oncology Shares Rise on Sales Outlook Lift
Dow Jones · 08/07 11:31
The Oncology Institute GAAP EPS of -$0.08 misses by $0.02, revenue of $161.28M beats by $6.08M
Seeking Alpha · 08/06 21:33
Press Release: Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Dow Jones · 08/06 20:14
Analyst Maintains Buy on Starling Oncology Rebrand, Keeps $7 Price Target Unchanged
TipRanks · 08/03 13:55
More
Webull provides a variety of real-time STLNW stock news. You can receive the latest news about Starling Oncology Inst Inc through multiple platforms. This information may help you make smarter investment decisions.
About STLNW
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.